Find a Tender
complete
Official procurement procedure
IRLA - Antibodies and Sera (and other matrices)
Antisera
General anti-infectives for systemic use and vaccines
General anti-infectives for systemic use
+4 more
UK
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Southern Universities Purchasing Consortium (SUPC): "IRLA - Antibodies and Sera (and other matrices)". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Southern Universities Purchasing Consortium (SUPC) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Southern Universities Purchasing Consortium (SUPC)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Southern Universities Purchasing Consortium (SUPC). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
7.6Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 91 active published awards; 85 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthoritySouthern Universities Purchasing Consortium (SUPC) | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published29 Jul 2021, 14:53 BST | Last source update29 Jul 2021, 14:53 BST | Recurring procurementNot published |
ClassificationAntisera, General anti-infectives for systemic use and vaccines, General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Immune sera and immunoglobulins, Immunoglobulins | ||
Delivery area UK | ||
OCIDocds-h6vhtk-0292a6 | ||
What is being bought
The supply of antibodies and sera (and other human and animal matrices).
Only members of www.apuc-scot.ac.uk , www.hepcw.ac.uk , www.lupc.ac.uk , www.neupc.ac.uk,www.nwupc.ac.uk , www.supc.ac.uk will have access to the agreement.
What changed
From the official release history
- tender value changed
29 Jul 2021, 14:53 BST - Status changed to complete
29 Jul 2021, 14:53 BST - Official notice release published
29 Jul 2021, 14:53 BST - Submission deadline changed to published date
29 Jul 2021, 14:53 BST - Published value updated to £32,100,000
12 Feb 2021, 11:05 GMT - Status changed to active
12 Feb 2021, 11:05 GMT - Official notice release published
12 Feb 2021, 11:05 GMT - Submission deadline changed to 26 Mar 2021, 14:00 GMT
12 Feb 2021, 11:05 GMT - Buyer information updated
12 Feb 2021, 11:05 GMT
Lots and requirements (2)
Published by the contracting authority
- Lot 1 · #1AntibodiescancelledPublished valueNot publishedPrecise product specifications and quantities are unknown to SUPC. These will be agreed with customers when they call-off the agreement. Historical information has shown on average a £10M per year spend with Antibodies suppliers. However, this is only an estimation and the value of purchases made under each Framework will depend on Institutions taking up the Frameworks and on suppliers promoting and adhering to the terms of their contracts Additional information: It is anticipated that some of the future call-off contracts under this framework will be part or fully funded from external streams, including European Union (EU) funding (ERDF/ESF) and potentially other research bodies. All funding accessed under this framework will be considered compliant for the purposes of external funding by the named participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Sera and other matricescancelledPublished valueNot publishedPrecise product specifications and quantities are unknown to SUPC. These will be agreed with customers calling-off the agreement. Expenditure across sera suppliers was estimated at less than 2 500 000 GBP for sera, tissue and other blood products. However, this is only an estimation and the value of purchases made under each Framework will depend on Institutions taking up the Frameworks and on suppliers promoting and adhering to the terms of their contracts. Additional information: It is anticipated that some of the future call-off contracts under this framework will be part or fully funded from external streams, including European Union (EU) funding (ERDF/ESF) and potentially other research bodies. All funding accessed under this framework will be considered compliant for the purposes of external funding by the named participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
29 Jul 2021, 14:53 BST - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 1 Jul 2021, 00:00 BST · £25,000,000 - Contract active
Signed 1 Jul 2021, 00:00 BST · £7,100,000
Commercial outcome and competition
Awards 2BScientific Ltd, Agilent Technologies LDA UK Ltd, Antibodies.com Limited, Bio-Techne Limited, BioLegend UK Ltd, BioServUK Ltd, Cambridge Bioscience Ltd, Cell Signaling Technology Europe BV, Enzo Life Sciences (UK) Ltd, Fisher Scientific UK LTD, Generon Ltd, Insight Biotechnology Limited, Merck Life Science UK limited, Miltenyi Biotec Ltd, Oxford Biosystems Ltd, Proteintech Europe Ltd, Stratech Scientific Ltd, Takara Bio Europe SAS Not published · Not published · active 2BScientific Ltd, Agilent Technologies LDA UK Ltd, Antibodies.com Limited, BioServUK Ltd, Fisher Scientific UK LTD, Merck Life Science UK limited, Stratech Scientific Ltd, Takara Bio Europe SAS Not published · Not published · active |
Contracts Antibodies £25,000,000 · signed 1 Jul 2021, 00:00 BST · active Sera and other matrices £7,100,000 · signed 1 Jul 2021, 00:00 BST · active |
Bid statistics bids: 19 (lot 1) electronicBids: 19 (lot 1) foreignBidsFromEU: 1 (lot 1) foreignBidsFromNonEU: 0 (lot 1) smeBids: 13 (lot 1) bids: 8 (lot 2) electronicBids: 8 (lot 2) foreignBidsFromEU: 8 (lot 2) foreignBidsFromNonEU: 0 (lot 2) smeBids: 5 (lot 2) |
Buyer and organisations in this procedure
Southern Universities Purchasing Consortium (SUPC)
Contracting authority GB-FTS-5463Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleNot published |